Nalaganje...
Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic
Shranjeno v:
| izdano v: | J Am Heart Assoc |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721902/ https://ncbi.nlm.nih.gov/pubmed/29054841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007665 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|